189 related articles for article (PubMed ID: 38435753)
1.
Nemidkanam V; Banlunara W; Chaichanawongsaroj N
Int J Nanomedicine; 2024; 19():1967-1983. PubMed ID: 38435753
[TBL] [Abstract][Full Text] [Related]
2. Characterizing Kaempferia parviflora extracellular vesicles, a nanomedicine candidate.
Nemidkanam V; Chaichanawongsaroj N
PLoS One; 2022; 17(1):e0262884. PubMed ID: 35077499
[TBL] [Abstract][Full Text] [Related]
3. Response to Article "
Yuliandari P; Maha MS; Panjaitan NSD
Int J Nanomedicine; 2024; 19():2993-2994. PubMed ID: 38544952
[No Abstract] [Full Text] [Related]
4. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury.
Park HS; Wijerathne CUB; Jeong HY; Seo CS; Ha H; Kwun HJ
J Ethnopharmacol; 2018 Apr; 216():239-250. PubMed ID: 29410309
[TBL] [Abstract][Full Text] [Related]
5. Ethyl acetate extract of Kaempferia parviflora inhibits Helicobacter pylori-associated mammalian cell inflammation by regulating proinflammatory cytokine expression and leukocyte chemotaxis.
Nemidkanam V; Kato Y; Kubota T; Chaichanawongsaroj N
BMC Complement Med Ther; 2020 Apr; 20(1):124. PubMed ID: 32321502
[TBL] [Abstract][Full Text] [Related]
6. An all-in-one therapeutic platform for the treatment of resistant Helicobacter pylori infection.
Sun C; Huang J; Guo X; Zhang C; Wei L; Wong KI; Yang Z; Zhao G; Lu M; Yao W
Biomaterials; 2024 Jul; 308():122540. PubMed ID: 38537343
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis.
Arenas A; Serrano C; Quiñones L; Harris P; Sandoval M; Lavanderos M; Sepúlveda R; Maquilón S; Echeverría A; Ríos C; Fuentes-López E; Rojas L; Jorquera A; Pizarro M; Camargo MC; Riquelme A
Sci Rep; 2019 Dec; 9(1):20070. PubMed ID: 31882676
[TBL] [Abstract][Full Text] [Related]
8. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides.
Kocsmár É; Buzás GM; Szirtes I; Kocsmár I; Kramer Z; Szijártó A; Fadgyas-Freyler P; Szénás K; Rugge M; Fassan M; Kiss A; Schaff Z; Röst G; Lotz G
Nat Commun; 2021 Apr; 12(1):2255. PubMed ID: 33859206
[TBL] [Abstract][Full Text] [Related]
9. Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Su T; Li F; Guan J; Liu L; Huang P; Wang Y; Qi X; Liu Z; Lu L; Wang D
Phytomedicine; 2019 Oct; 63():152968. PubMed ID: 31280140
[TBL] [Abstract][Full Text] [Related]
10. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Gisbert JP; Carpio D; Marcos S; Gisbert JL; García Grávalos R; Pajares JM
Eur J Gastroenterol Hepatol; 2000 May; 12(5):489-95. PubMed ID: 10833090
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin modulates Helicobacter pylori-induced activation of nuclear factor-κB through classical and alternative pathways in gastric epithelial cells.
Peng YC; Ho SP; Shyu CL; Chang CS; Huang LR
Clin Exp Med; 2014 Feb; 14(1):53-9. PubMed ID: 23129507
[TBL] [Abstract][Full Text] [Related]
12. The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471.
Geng X; Li W; Chen Z; Gao S; Hong W; Ge X; Hou G; Hu Z; Zhou Y; Zeng B; Li W; Jia J; Sun Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242673
[TBL] [Abstract][Full Text] [Related]
13. Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo.
Tian A; Xu T; Liu K; Zou Q; Yan X
Chin Med J (Engl); 2014; 127(13):2484-91. PubMed ID: 24985588
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Clarithromycin Depends on the Bacterial Density in Clarithromycin-Heteroresistant
Kim JJE; Kocsmár I; Buzás GM; Szirtes I; Rusz O; Diczházi C; Szijártó A; Hritz I; Schaff Z; Kiss A; Kocsmár É; Lotz G
Pathol Oncol Res; 2021; 27():1609863. PubMed ID: 34267605
[TBL] [Abstract][Full Text] [Related]
15. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
Kutluk G; Tutar E; Bayrak A; Volkan B; Akyon Y; Celikel C; Ertem D
Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1202-8. PubMed ID: 25171023
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequencing reveals novel genetic mutations of Helicobacter pylori associating with resistance to clarithromycin and levofloxacin.
Lyu T; Cheung KS; Deng Z; Ni L; Chen C; Wu J; Leung WK; Seto WK
Helicobacter; 2023 Aug; 28(4):e12972. PubMed ID: 36965192
[TBL] [Abstract][Full Text] [Related]
17. Preparation of Corn Peptides with Anti-Adhesive Activity and Its Functionality to Alleviate Gastric Injury Induced by
Li G; Liu X; Miao Z; Hu N; Zheng X
Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571404
[TBL] [Abstract][Full Text] [Related]
18. Effects of radix curcumae-derived diterpenoid C on Helicobacter pylori-induced inflammation and nuclear factor kappa B signal pathways.
Huang X; Lv B; Zhang S; Dai Q; Chen BB; Meng LN
World J Gastroenterol; 2013 Aug; 19(31):5085-93. PubMed ID: 23964142
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells.
Kim JM; Kim JS; Jung HC; Oh YK; Kim N; Song IS
Helicobacter; 2003; 8(5):542-53. PubMed ID: 14536001
[TBL] [Abstract][Full Text] [Related]
20. The outward shift of clarithromycin binding to the ribosome in mutant Helicobacter pylori strains.
Salehi N; Attaran B; Zare-Mirakabad F; Ghadiri B; Esmaeili M; Shakaram M; Tashakoripour M; Eshagh Hosseini M; Mohammadi M
Helicobacter; 2020 Dec; 25(6):e12731. PubMed ID: 32794288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
